Skip to content

Potassium Bicarbonate

  • Prescription medicine
  • Prescription only
  • Identity checked
  • Sources last checked 2026-09-04

This page shows what was measured, who it was measured in, and what that does not settle.

What Potassium Bicarbonate does in the body

Hypokalemia, with or without metabolic alkalosis

From the FDA-approved label: Potassium ion is the principal intracellular cation of most body tissues, whereas sodium ion is relatively low in concentration. In extracellular fluid the opposite exists, sodium ion being principal and potassium ion being low. The situation is maintained by an active membrane-bound enzyme (Na + K + ATPase). This potassium ion concentration gradient is essential to conduct nerve impulses in such specialized tissues as the brain, heart, and skeletal muscle; and in addition, to maintain normal renal function, acid-base balance, and various cellular metabolic functions. Elimination values are 90% renal and 10% fecal.

What happened in people

RNAWiki has not yet published a reviewed conclusion for this use.

A fixed RNAWiki sentence

Where this came from

Wording RNAWiki always uses, not a finding about this substance.

No reviewed claim names a result for any goal on this record.

No source is stored against this line.

The limit that matters most

Not recorded.

Where it acts
Not recorded.
Kind of result
No result is published, so no kind of result applies yet
Supervision
RNAWiki has not recorded a supervision or regulatory status for this substance.

What the registries record it as

  • The substance registry classes this as chemical.

    FDA substance registry · HM5Z15LEBN · read 2026-08-29

  • The supplement label database classes it as mineral, under the name Calcium.

    NIH Dietary Supplement Label Database · 27 · read 2026-08-29

  • Its recorded molecular formula is NaHCO3, weighing 84.01.

    US prescribing information · b50c858a-00c8-4cb2-ad73-8797f19e656d · read 2026-08-30

Where each sentence above came from

No recorded sentence describes the change this makes in a way that stands on its own. The page opens with what it is taken for instead, and the recorded explanation follows below.

Shown as the opening line on this page.

No statement of the main limit is recorded.

The four opening statements run to 114 words.

Words this page uses

Four words worth knowing first

Chosen from what this page shows, with each one explained before the word it depends on.

Biomarker

A biomarker is a number from a test that stands in for something about health.

A picture of it, and where the picture fails

A biomarker is like a fuel gauge.

Where that stops being true. A gauge is wired to the tank. Many biomarkers are only loosely tied to health.

What people get wrong. A better number is read as a better life. Several medicines improved a number and helped nobody.

A measurable indicator used as a substitute for a clinical outcome of interest.

Stand-in result

A stand-in result is a number measured because the real result takes too long.

A picture of it, and where the picture fails

It is like judging a journey by the speedometer rather than by arriving.

Where that stops being true. Speed does predict arrival. Many stand-in results do not predict the real one.

What people get wrong. A stand-in result is often reported as the result itself.

A surrogate endpoint substituted for a clinical endpoint, valid only where the substitution has been shown to hold.

What happened in peopleRead from sources, not yet reviewed

What happened in people

Each card is one study: the exact question it asked, who was in it, and whether it showed what it set out to show.

The incidence density

The study did not show it

Who was studied
NCT05470855
How many people
45400
Study design
Phase 4
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot

GMT of varicella antibody in children aged 1-6 years

The study did not show it

Who was studied
NCT05460429
How many people
37920
Study design
Phase 4
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot

Cardiovascular risk as assessed by Modified Moli-Sani risk score in the Italian population

The study did not show it

Who was studied
NCT05339841
How many people
27520
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot

Stroke

The study did not show it

Who was studied
NCT02092090
How many people
20996
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot

All-cause mortality

The study did not show it

Who was studied
NCT02735707
How many people
20000
Study design
Phase 3
Compared against
Not recorded for this study
Kind of result
Living longer, or avoiding a major event
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot

Primary outcome for the main study-Systolic blood pressure

The study did not show it

Who was studied
NCT06097884
How many people
16000
Study design
Not applicable
Compared against
Not recorded for this study
Kind of result
A number that stands in for health
What was found
Result not recorded on this page
Repeated elsewhere
Unreplicated

What this does not prove. A study that did not show an effect does not show that no effect exists anywhere.

The limits of this study, and where it came from

Main limit. No limitation is recorded for this study.

How far it carries. This study is recorded from the curated record, not from the registry match.

Form and route. Oral

Interval reported. Not recorded in this summary

Written into the record, not signed off as a reviewed claim.

  • openFDA NDC Directory · a recorded source, not a stored snapshot
  • openFDA SPL label · a recorded source, not a stored snapshot
  • PubChem PUG-REST · a recorded source, not a stored snapshot
  • FDA label (openFDA SPL) · a recorded source, not a stored snapshot
What we know
RNAWiki holds 6 written-up human studies for this substance, each with the question it asked.
How we know it
Each card names the study, the number of people and what the study set out to measure.
What this does not prove
These summaries were written by a person and have not been signed off as reviewed claims.
Why it matters
A study that failed is as informative as one that worked, and both are here.
What we still do not know
No reviewed claim exists, so no exact population, effect size or interval is published yet.

What happened in peopleRead from sources, not yet reviewed

How close this is to real life

The top step is something a person would feel or care about. The bottom is a guess from software. Filled steps are where evidence exists for this substance.

  1. Living longer, or avoiding a major event No evidence recorded. Death, a heart attack, a stroke, a hospital stay.No registered study measures this.
  2. What a body can do day to day No evidence recorded. Walking, dressing, breathing, recovering.No registered study measures this.
  3. Measured performance No evidence recorded. How much was lifted, how far was run, how fast.No registered study measures this.
  4. Symptoms and quality of life No evidence recorded. Pain, tiredness, mood, sleep, as the person rated it.No registered study measures this.
  5. A number that stands in for health Evidence recorded. Cholesterol, blood sugar, bone density. A stand-in, not the thing itself.11 registered measures of this kind.
  6. A step measured inside a person Evidence recorded. Something measured in human tissue or human cells.A human record sits on the stored organism ladder.
  7. Animals No evidence recorded. Mice, rats, dogs. Useful for ideas, not proof about people.No animal record is stored.
  8. Cells in a dish No evidence recorded. Cells or chemistry on a bench, far from a whole body.No cell or bench record is stored.
  9. A guess from software No evidence recorded. Nobody measured it. RNAWiki never publishes one as a finding.RNAWiki stores no prediction for this record. Software can suggest a link. RNAWiki does not publish one as a finding.

Higher on these steps means closer to something a person would feel. It does not mean better done.

What it would be like to takeRead from sources, not yet reviewed

Felt, measured, or meaningful

Three different things that get called the same word. Registered studies measured all three, and mixing them is how a blood test becomes a health claim.

Felt

Things a person could notice without a test.

No registered study measured anything of this kind.

Measured

Things only a test, a scale or a device shows.

  • bone mineral density by test at 1 and 2 years
  • bone mineral density under treatment an anabolic agent
  • lumbar spine bone mineral density at 12 months
  • bone mineral density
  • bone mineral density t from baseline to 12 months
  • blood lead concentration plasma lead concentration
  • increased base line creatinine at least 25
  • serum bicarbonate levels
  • serum age levels
  • ambulatory blood pressure

and 1 more.

Meaningful

Things that change how a life goes, not only a number.

No registered study measured anything of this kind.

A registered study says what someone planned to measure. It does not say what they found. A number moving is not the same as a life going better. The two are shown apart here.

Felt, but not shown to help. A person notices a change. No study showed it leads anywhere good.

Measured, but not felt. A number moves. The person notices nothing. Both can be true.

Measured, but not shown to matter. A number moves in the good direction. Nobody showed that lives went better.

Matters, but takes years. The result that counts may take longer than anyone would keep watching.

Names that fit none of the three (29)
  • mammographic density at 1 year on exemestane
  • lumbar spine bmd at 24 months
  • lumbar spine bmd at 36 months
  • lumbar spine bmd at 60 months
  • lumbar spine bmd at 120 months
  • colorectal adenomas
  • biochemical markers of bone turnover
  • contrast induced nephropathy
  • who developed acute kidney injury within 72 hours
  • incidence of contrast induced nephropathy
  • development of contrast induced nephropathy
  • base study + first extension rate of adverse events
  • second extension number of who experienced an adverse event
  • bone formation rate
  • that experienced an adverse event
  • that discontinued study drug due to an ae
  • contrast induced nephropathy incidence
  • occurrence of contrast induced nephropathy
  • that discontinued study treatment due to an ae
  • acute kidney injury

These are harms, study-process measures, or names the rules did not recognise. They are shown rather than dropped.

What is missing or unclearRead from sources, not yet reviewed

Were people like you studied?

RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.

Who was studied

People similar to this profile were included.

  • For the treatment of patients with hypokalemia, with or without metabolic alkalosis; in digitalis intoxication; and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia.

Who is missing from the studies

  • Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What the label states about particular groups

  • On pediatric, the label states: “The rate of administration in such patients should therefore be limited to no more than 8 mEq/kg/day.”

    US prescribing information · b50c858a-00c8-4cb2-ad73-8797f19e656d · read 2026-08-30

  • On older people, the label states: “Clinical studies of sodium bicarbonate injection did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.”

    US prescribing information · b50c858a-00c8-4cb2-ad73-8797f19e656d · read 2026-08-30

  • On people who are pregnant, the label states: “Risk Summary Available data from published literature over decades of use have not identified a drug associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes.”

    US prescribing information · b50c858a-00c8-4cb2-ad73-8797f19e656d · read 2026-08-30

  • On people who are breastfeeding, the label states: “Risk Summary There are no data on the presence of sodium bicarbonate in either human or animal milk, the effects on the breast-fed infant or the effects on milk production following administration of sodium bicarbonate injection.”

    US prescribing information · b50c858a-00c8-4cb2-ad73-8797f19e656d · read 2026-08-30

Where the result stopped carrying

  • This is a scope explorer, not a diagnosis engine.
  • It shows who was studied so you can see whether people similar to you were included.

RNAWiki cannot tell whether a study fits you. It can show who was in it.

What it would be like to takeRead from sources, not yet reviewed

Why it might seem to do nothing

A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.

It was studied for a different goal

The studies measured something else entirely.

On this record: Some registered studies measured things that match no goal on this page.

It was studied in different people

The people in the studies were not much like the reader.

On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

The evidence may simply be wrong

Small early studies often do not hold up.

On this record: RNAWiki has not yet published a reviewed conclusion for this use.

Other reasons RNAWiki checked and found nothing for (10)
A different form was studied
The studied form is not the form on the shelf. Nothing in this record points to this reason.
There was nothing to correct
Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
Something else had to happen too
In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
The change is too small to feel
A real change can still sit below what a person notices. Nothing in this record points to this reason.
Day-to-day swing hides it
Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
Not enough time yet
The studies ran longer than the person has waited. Nothing in this record points to this reason.
It was not taken as studied
Missed days change the result, and studies count them. Nothing in this record points to this reason.
Something else changed at the same time
Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
The product may not be what it says
Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
No recorded reason
RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.

None of these is a reason to take more. Taking more is not a step this page ever suggests.

What it would be like to takeRead from sources, not yet reviewed

What taking it involves

The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.

How it is supplied

Prescription only

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

Read from the recorded approval status.

No source is stored against this line.

Form and route

Oral

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form and route recorded on this substance.

No source is stored against this line.

Who oversees it

RNAWiki has not recorded a supervision or regulatory status for this substance.

Quoted from a source

Where this came from

Copied from a source RNAWiki stored, with the source named.

No register row and no identity class settled the question.

No source is stored against this line.

What is in the pack

Sold as tablet, effervescent, given by the oral route.

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

Recorded notes on how this is sold and what that means for what is in the pack.

No source is stored against this line.

Where it is registered

Regulatory records are listed in the technical disclosure at the foot of this page.

Counted from records

Where this came from

A count of rows RNAWiki holds. It describes our records, not your body.

Register entries are stored per jurisdiction and shown with their dates.

No source is stored against this line.

Why people stop

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

No record of why people stopped taking it is stored for this substance.

No source is stored against this line.

What it would be like to takeNothing found in the sources checked

What can go wrong

Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.

Nothing found in the sources checked

No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.

The sources listed were searched and held nothing. That is not the same as nothing existing.

Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.

Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.

What is missing or unclearRead from sources, not yet reviewed

Does the exact form matter?

Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.

The form that was studied

Oral

Source-linked record

Where this came from

A person wrote this into the record with the study named beside it. No reviewer has signed it off.

The form used in the studies cited on this page.

No source is stored against this line.

What is sold

Not recorded.

Nothing recorded

Where this came from

RNAWiki holds nothing here and says so rather than guessing.

Nothing further is recorded about which forms are sold.

No source is stored against this line.

What is recorded as being sold

  • 216 published labels name it as an active ingredient. 100 of them describe this substance alone, which is where its own label text on this page comes from.

    US prescribing information · 9cdde58a-ae8a-451f-92cf-cab178e4ba92 · read 2026-08-29

  • Those labels are classed as human otc drug and human prescription drug.

    US prescribing information · 9cdde58a-ae8a-451f-92cf-cab178e4ba92 · read 2026-08-29

  • 6480 marketed supplement labels list this ingredient, classed as mineral and other.

    NIH Dietary Supplement Label Database · 272817 · read 2026-08-29

  • Those labels carry all other, nutrient and structure/function claims. A claim of that kind is written by the manufacturer and is not assessed by any regulator, so its presence says nothing about whether it is true.

    NIH Dietary Supplement Label Database · 272817 · read 2026-08-29

  • sodium bicarbonate is intravenous at 3 DOSAGE FORMS AND STRENGTHS Sodium Bicarbonate Injection is a clear, colorless, sterile, nonpyrogenic, isotonic solution intended for intravenous use and available as: Injection: 12.6 mg/mL (0.150 mEq/mL), 12,600 mg of…, recorded as fda label in effect 2026-08-14 in the United States.

    US prescribing information · b50c858a-00c8-4cb2-ad73-8797f19e656d · read 2026-08-30

Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.

What it would be like to takeRead from sources, not yet reviewed

What you could measure

This one is decided with a clinician, so this section holds questions to ask rather than a plan to run.

RNAWiki could not confidently classify this substance, so no self-experiment plan is offered.

Questions worth asking

  • Which of the trials of Potassium Bicarbonate studied people like me?
  • What was measured, and for how long?
  • Was the result a laboratory value or a health outcome?
  • What would we watch for, and when would we stop?

Tracking can show whether something changed for you. It cannot show what caused it.

RNAWiki records evidence. It does not say whether this substance is right for you.

What is missing or unclearRead from sources, not yet reviewed

What nobody knows yet

Open questions, each with why it is open and what would close it.

How fast does the body clear it?

The sources RNAWiki checked hold nothing for this field.

Why it matters. Without this, nothing on this page can say how long anything lasts.

What would answer it

A stored source that records it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing populations

Which groups were under-represented in the studies has not been recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing long-term data

No completed tested study window is recorded.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

No reviewed conclusion

RNAWiki has not yet published a reviewed conclusion for this use.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Missing interaction studies

No interaction was found in the registers checked. Not finding one is not the same as showing there is none.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Formulation uncertainty

Several salts, forms or products of Potassium Bicarbonate are recorded. Results from one form may not transfer to another.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

Mechanism not reviewed

No reviewed mechanism story exists for this substance.

Why it matters. Recorded by the evidence model as a gap on this record.

What would answer it

A study that measures it, and a reviewer to sign it off.

Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.

What happened in peopleRead from sources, not yet reviewed

Check any of this yourself

Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.

Where else this substance is registered

FDA substance identifier (UNII)
HM5Z15LEBN
RxNorm concept
1111261

Checks this page had to pass

  • Passed

    Identity resolved

    no open identity hold

  • Passed

    No unresolved merge across substance families

    no quarantine open

  • Passed

    Every public sentence names a source

    The opening statement carries the origin: Written into the record, not signed off.

  • Not passed

    Trial roles classified for highlighted evidence

    No registered study is classified as testing this substance.

  • Passed

    No internal keys in reader text

    enforced by the copy-contract test over the rendered page

  • Not passed

    Safety mode resolved

    No register row and no identity class settled the question.

  • Passed

    Canonical metadata present

    slug and display name present

What is missing or unclearRead from sources, not yet reviewed

What to learn next

Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.

This order is fixed in code and does not count clicks or time on the page.

What is not here

8 questions this page could not answer

These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.

  • What was measured, goal by goal — found nothing in the sources checked.
  • The path through the body — found nothing in the sources checked.
  • How long anything takes — found nothing in the sources checked.
  • What it may clash with — found nothing in the sources checked.
  • Other ways to the same goal — found nothing in the sources checked.
  • Claims that go past the evidence — found nothing in the sources checked.
  • How this medicine reached us — found nothing in the sources checked.
  • What changed on this page — found nothing in the sources checked.

The record as stored

The full record, for auditing

Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.

Recorded evidence blocks (10)

What did Potassium Bicarbonate's largest trial (16071 people) and its longest (18 years) measure?


16071 people in Potassium Bicarbonate's largest registered study, 18 years in its longest registered window, measuring Rate of Biological Aging. ClinicalTrials.gov · 2026-09-01

89 na, 53 phase2, 47 phase4, 46 phase3, 25 phase1, 9 early phase1, 3 na or unstated; NCT06545461; 2016-10-30. Last human test completed 2026, NCT05424263.

Interpretation These counts include studies where Potassium Bicarbonate was a comparison treatment, a background treatment or an exposure in an observational study, and the longest window may be a planned end date. Trial roles have not yet been classified for this record.

Show the evidence
  • na
    89
  • phase2
    53
  • phase4
    47
  • phase3
    46
  • phase1
    25
  • early phase1
    9
2 more recorded rows
  • na or unstated
    3
  • Last recorded human test NCT05424263
    2026-03-19

recorded 2026-09-01 · last checked 2026-09-04

Potassium Bicarbonate was tested only in human — what did it show?


human: mechanism-only (260): the rungs where Potassium Bicarbonate has a recorded finding. Europe PMC and ClinicalTrials.gov · organism ladder · 2026-09-01

Interpretation Rate of Biological Aging — the recorded outcome words.

Yeast C. elegans Drosophila Mouse Rat Dog Non-human primate Human mechanism-only
Show the evidence
  • human NCT05302713
    mechanism-only; Rate of Biological Aging; 260

recorded 2026-09-01 · last checked 2026-09-04

20 of Potassium Bicarbonate's trials stopped: safety, futility/efficacy, accrual/recruitment, funding/business, sponsor decision unspecified, other?


safety (1), futility/efficacy (2), accrual/recruitment (7), funding/business (1), sponsor decision unspecified (1) and other (8): Potassium Bicarbonate's stop wording, clustered. ClinicalTrials.gov · 2026-09-01

"Lack of funding"; 20 of 260 registered studies

Show the evidence

Trial

  • NCT00384995
    terminated; "Lack of funding"
  • NCT00470353
    terminated; "Withdrawn due to poor accrual/lack of funding"
  • NCT00494637
    terminated; "Not reaching recruitment and endpoint goals"
  • NCT00579995
    terminated; "Technical measurement problems led to unreliable or uninterpretable data."
  • NCT00650637
    terminated; "The study was prematurely discontinued due to administrative reasons on August 18, 2003. There were no safety concerns that led to the decision to terminate."
  • NCT00837655
    withdrawn; "PI retired"
14 further recorded trials
  • NCT01093131
    withdrawn; "Investigator left institution"
  • NCT01350583
    terminated; "PI Left Moffitt"
  • NCT01846429
    terminated; "Drugs unavailable. Study did not progress to Phase 2."
  • NCT01894594
    terminated; "Poor recruitment"
  • NCT02046135
    terminated; "Statistical analysis at interim analysis determined futility in continuing."
  • NCT02282384
    withdrawn; "Sites were unable to recruit participants"
  • NCT02647892
    terminated; "IRB protocol administratively closed, Continuing Review or Study Completion Report not submitted"
  • NCT02743650
    terminated; "Difficulties identifying subjects who were qualified to participate in the study"
  • NCT03113994
    terminated; "COVID-19 Pandemic"
  • NCT03461354
    terminated; "Interim analysis indicated study closure"
  • NCT03612466
    withdrawn; "Study withdrawn before any participants could be enrolled. Issues being able to effectively recruit participants into the study."
  • NCT04530448
    terminated; "Unable to recruit enough subjects to complete the study. Only 3 subjects enrolled. However, those subjects did not complete the study as the PI terminated the study and data was not collected."
  • NCT05302713
    withdrawn; "No participants were enrolled"
  • NCT06047366
    terminated; "Student PI is preparing for graduation and cannot complete the study as planned."

recorded 2026-09-01 · last checked 2026-09-04

Human studies of Potassium Bicarbonate used 8.4% w/v Sodium bicarbonate B Braun Melsungen, Germany. — over how long?


Human studies of Potassium Bicarbonate used "8.4% w/v Sodium bicarbonate B Braun Melsungen, Germany." ClinicalTrials.gov · 2026-09-01

11 recorded entries; human; also "Sodium Bicarbonate Inj., 8.4% USP Neutralizing Additive Solution (NDC Code 509-100-03)", "Calcium Carbonate 1200 mg", "sodium bicarbonate 500mg capsules"

Show the evidence

human

  • NCT01219322
    8.4% w/v Sodium bicarbonate B Braun Melsungen, Germany.
  • NCT01622296
    Sodium Bicarbonate Inj., 8.4% USP Neutralizing Additive Solution (NDC Code 509-100-03)
  • NCT01762995
    Calcium Carbonate 1200 mg
  • NCT02692378
    sodium bicarbonate 500mg capsules
  • NCT04479566
    Calcium Carbonate 500 MG
  • NCT04806061
    sodium bicarbonate 8.4%
5 more recorded rows
  • human NCT05577507
    Calcium Carbonate 500 MG Oral Tablet
  • human NCT05870007
    Sodium Bicarbonate 600 Mg Oral Tablet
  • human NCT06047366
    Onset Sodium Bicarbonate Inj., 8.4%, USP Neutralizing Additive Solutio
  • human NCT06292091
    Sodium bicarbonate 4 G
  • human NCT06999993
    Sodium bicarbonate 8.4% Solution for Injection

recorded 2026-09-01 · last checked 2026-09-04

Could one person measure Potassium Bicarbonate's effect on bone mineral density by test at 1 and 2 years?


Bone mineral density by test at 1 and 2 years: measured in Potassium Bicarbonate's trials.

bone mineral density by test at 1 and 2 years is the recorded endpoint.

Show the evidence

biomarkers

  • bone mineral density by test at 1 and 2 years; 2026-09-01
  • mammographic density at 1 year on exemestane; 2026-09-01
  • bone mineral density under treatment an anabolic agent; 2026-09-01
  • lumbar spine bone mineral density at 12 months; 2026-09-01
  • lumbar spine bmd at 24 months; 2026-09-01
  • lumbar spine bmd at 36 months; 2026-09-01
14 more recorded rows
  • biomarkers
    lumbar spine bmd at 60 months; 2026-09-01
  • biomarkers
    lumbar spine bmd at 120 months; 2026-09-01
  • biomarkers
    colorectal adenomas; 2026-09-01
  • biomarkers
    bone mineral density; 2026-09-01
  • biomarkers
    bone mineral density t from baseline to 12 months; 2026-09-01
  • biomarkers
    biochemical markers of bone turnover; 2026-09-01
  • biomarkers
    contrast induced nephropathy; 2026-09-01
  • biomarkers
    who developed acute kidney injury within 72 hours; 2026-09-01
  • biomarkers
    incidence of contrast induced nephropathy; 2026-09-01
  • biomarkers
    development of contrast induced nephropathy; 2026-09-01
  • biomarkers
    base study + first extension rate of adverse events; 2026-09-01
  • biomarkers
    second extension number of who experienced an adverse event; 2026-09-01
  • biomarkers
    blood lead concentration plasma lead concentration; 2026-09-01
  • biomarkers
    bone formation rate; 2026-09-01
  • human trials at or under30
    65
  • Not recorded for this substance
    a recorded half-life
  • smallest human trial
    0; NCT00837655; NA; the smallest recorded human enrolment at or below 30; the registry states no direction of its result; WITHDRAWN

Which of acute kidney injury, all type cancer and ambulatory blood pressure did Potassium Bicarbonate's trials measure?


acute kidney injury, all type cancer and ambulatory blood pressure lead 40 outcome terms across Potassium Bicarbonate's trials. ClinicalTrials.gov · 2026-09-01

lumbar spine bone mineral density at 12 months, lumbar spine bmd at 24 months, lumbar spine bmd at 36 months, lumbar spine bmd at 60 months, lumbar spine bmd at 120 months and colorectal adenomas follow.

Show the evidence
  • bone mineral density by test at 1 and 2 years
    1
  • mammographic density at 1 year on exemestane
    1
  • bone mineral density under treatment an anabolic agent
    1
  • lumbar spine bone mineral density at 12 months
    1
  • lumbar spine bmd at 24 months
    1
  • lumbar spine bmd at 36 months
    1
14 more recorded rows
  • lumbar spine bmd at 60 months
    1
  • lumbar spine bmd at 120 months
    1
  • colorectal adenomas
    1
  • bone mineral density
    1
  • bone mineral density t from baseline to 12 months
    1
  • biochemical markers of bone turnover
    1
  • contrast induced nephropathy
    1
  • who developed acute kidney injury within 72 hours
    1
  • incidence of contrast induced nephropathy
    1
  • development of contrast induced nephropathy
    1
  • base study + first extension rate of adverse events
    1
  • second extension number of who experienced an adverse event
    1
  • blood lead concentration plasma lead concentration
    1
  • bone formation rate
    1

recorded 2026-09-01 · last checked 2026-09-04

Which of Potassium Bicarbonate's 32 ongoing trials reports first?


32 registered trials of Potassium Bicarbonate are open; earliest completion 2025-12. ClinicalTrials.gov · 2026-09-01

Change in muscle oxygenation after exercise/stretching training; 24 hour urine volume; latest 2029-04

Show the evidence

Trial

  • NCT02411773
    "Sympatholysis in Chronic Kidney Disease"; n 110; "Change in muscle oxygenation after exercise/stretching training"; 2027-06
  • NCT04651088
    "Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet"; n 15; "24 hour urine volume"; 2027-07
  • NCT04984226
    "Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD"; n 80; "muscle mitochondrial oxidative capacity by 31P MRS"; 2026-12-31
  • NCT05005793
    "Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients"; n 120; "Change in Brachial artery flow mediated dilation at 12 months"; 2026-08-31
  • NCT05113641
    "Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)"; n 37; "Randomization to preliminary eligible ratio"; 2026-09
  • NCT05328180
    "aDjunct bicarbonatE in Local anaesthesIa for CarpAl Tunnel rElease (DELICATE)"; n 116; "Total pain level with visual analogic scale (VAS)"; 2025-12
14 further recorded trials
  • NCT05564130
    "Bicarbonate for In-Hospital Cardiac Arrest"; n 778; "Number of Participants With Return of Spontaneous Circulation"; 2027-02-11
  • NCT05571514
    "Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis"; n 200; "Change in bone loss at lumbar site"; 2028-11
  • NCT05697770
    "SODium BICarbonate for Metabolic Acidosis in the ICU"; n 500; "MAKE30 score"; 2026-07
  • NCT05719467
    "SAINT: Safe Induction of Labor Trial"; n 3000; "Spontaneous vs operative birth"; 2027-12-31
  • NCT05853692
    "Prevention of Oral Mucositis in Head and Neck Cancer."; n 130; "Oral Mucositis"; 2028-06-10
  • NCT05870007
    "Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease"; n 30; "Changes in kidney function in patients enrolled in different arms of the study"; 2026-12
  • NCT05928936
    "Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD"; n 156; "Change in Exercise Capacity"; 2028-06-01
  • NCT06249061
    "Oral Sodium Bicarbonate for the Prevention of Labour Dystocia"; n 200; "Feasibility of a full-scale RCT"; 2027-12
  • NCT06270134
    "Dial-Bicarb Trial: Effects of a Lower vs. Higher Concentration of Dialysate Bicarbonate"; n 14000; "Non-elective hospitalizations"; 2029-04
  • NCT06335537
    "Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers"; n 100; "Change in 24-hour Urinary pH"; 2026-07
  • NCT06352775
    "Calcium Carbonate on Labor Induction"; n 250; "Duration of induction time"; 2026-12-30
  • NCT06580782
    "Calcium Carbonate to Augment Labor Contractions"; n 60; "Number of Participants Consented"; 2025-12
  • NCT06660524
    "Calcium-Phosphorus Regulation Therapy on Heart Valve Disease"; n 196; "The change of valve calcification score on CT scan from baseline to 1 year of treatment."; 2025-12
  • NCT06826222
    "Sodium Bicarbonate Intake on Endurance Performance"; n 19; "10 km time-trial run"; 2026-12-31

recorded 2026-09-01 · last checked 2026-09-04

Which 117 trials of Potassium Bicarbonate posted no result?


Posted no result
117 of 117 completed trials
Registrations
NCT00000429, NCT00686192, NCT00004488, NCT00004489, NCT00302627 and NCT00558623, and 111 more
Completion dates
oldest 2001-05; newest 2024-05-01
Show the evidence

Trial

  • NCT00000429
    2001-05
  • NCT00686192
    2002-07
  • NCT00004488
    2002-09
  • NCT00004489
    2002-09
  • NCT00302627
    2002-11
  • NCT00558623
    2005-04
14 further recorded trials
  • NCT03813329
    2005-12-31
  • NCT03878667
    2005-12-31
  • NCT00312117
    2006-02
  • NCT00630214
    2006-02
  • NCT00606827
    2006-03
  • NCT01514851
    2006-05
  • NCT00334191
    2006-06
  • NCT00061256
    2006-09
  • NCT00560300
    2006-11
  • NCT00177645
    2006-12
  • NCT03286673
    2007-03
  • NCT00730184
    2007-12
  • NCT00634491
    2008-02
  • NCT00054418
    2008-05

At the median, Potassium Bicarbonate's trials enrolled 72 people — anything larger?


Median enrolment
72
Largest enrolment
16071
Registered trials counted
260

Was Potassium Bicarbonate studied with fasting?


fasting is named in Potassium Bicarbonate's label sentences: "To investigate the effects of short-term fasting on bone metabolism and the contribution of acidosis to these changes, 14 healthy women ages 18-26 (mean, 21 +/- 2 (SD years) were randomized to potassium bicarbonate (KHCO3, 2 meq/kg/day in divided doses) to prevent acidosis or control (potassium…" openfda-label+europepmc · 1995-12-01

1 recorded statement; fasting

Show the evidence
  • fasting
    To investigate the effects of short-term fasting on bone metabolism and the contribution of acidosis to these changes, 14 healthy women ages 18-26 (mean, 21 +/- 2 (SD years) were randomized to potassium bicarbonate (KHCO3, 2 meq/kg/day in divided doses) to prevent acidosis or control (potassium chloride, 25 meq/day) during a complete 4-day fast.

recorded 1995-12-01 · last checked 2026-09-04

Where it is registered
Identifiers, relations and other names

The exact record

ChEMBL id
CHEMBL2106975
PubChem CID
516893
CAS number
298-14-6
RxCUI
34296
InChIKey
TYJJADVDDVDEDZ-UHFFFAOYSA-M
Also called
Armicarb, Carbonic acid, monopotassium salt, Kafylox, Kaligreen, Khco3, Milstop, Purple k, POTASSIUM BICARBONATE [FCC], POTASSIUM BICARBONATE [II], POTASSIUM BICARBONATE [MART.]
Development code
E-501(II), INS-501(II), INS NO.501(II)
Salt form
Potassium carbonate solution, Potassium hydrogencarbonate, Effer-K 20 Meq Orange Cream, Effer-K Cherry Berry / Effer-K Unflavored / Effer-K 10 Meq Unflavored / Effer-K 20 Meq Unflavored / Effer-K 20 Meq Orange Cream / Effer-K 10 Meq Cherry Vanilla
Trade name
Pot eff, Effer-K Cherry Berry, Effer-K Unflavored, Effer-K 10 Meq Unflavored, Effer-K 20 Meq Unflavored, Effer-K 10 Meq Cherry Vanilla, KLOR-Con/EF, Effer-K Orange, Effer-K Lemon Citrus
Sources (7)

Sources

  • ClinicalTrials.gov clinicaltrials.gov ·
  • ClinicalTrials.gov ClinicalTrials.gov API v2 snapshot 2026-09-01T09:00:05 ·
  • this record's own fields 2,3,5 ·
  • Europe PMC dose-response search ·
  • Europe PMC and ClinicalTrials.gov organism ladder ·
  • openfda-label+europepmc K1:HM5Z15LEBN ·
1 more source

ChEMBL ATC CC BY-SA · ClinicalTrials.gov — US Government work · Europe PMC — metadata only, under the recorded legal gate · derived from this page's own recorded fields; no external licence · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md · openFDA / DailyMed — US Government work

How these records are assembled · Which registers were checked

Index-quality checks
  • identity passed: no open identity hold
  • required summary fields resolved: 4 required field(s) not terminal: Why people use it, Best-supported result, Biggest unanswered question, Human evidence
  • public claims reviewed: 0 reviewed claim(s); drafts are never rendered
  • source coverage passed: 7 source rows
  • no critical contamination: no quarantine open
  • canonical metadata passed: slug and display name present
  • no raw internal fields: enforced by the copy-contract test over the rendered page

This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.